Showing results (101-110 of 113) with videos related to

Sort By:
Pageof 12
AIDS (London, England)|November 30, 2020
Pharmacokinetics and safety of maraviroc in neonatesJulia C Rosebush, Brookie M Best, Ellen G Chadwick, et al.
Clinical Pharmacokinetics|March 29, 2025
Pharmacokinetics and Safety of Levofloxacin for Treatment of Rifampicin-Resistant Tuberculosis During Pregnancy and the Postpartum Period: Results from IMPAACT P1026sJennifer A Hughes, Mauricio Pinilla, Kristina M Brooks, et al.
Antimicrobial Agents and Chemotherapy|September 8, 2011
Pharmacokinetics and safety of single-dose tenofovir disoproxil fumarate and emtricitabine in HIV-1-infected pregnant women and their infantsPatricia M Flynn, Mark Mirochnick, David E Shapiro, et al.
Lancet (London, England)|September 19, 2003
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trialJ Brooks Jackson, Philippa Musoke, Thomas Fleming, et al.
Antimicrobial Agents and Chemotherapy|October 26, 2023
Pharmacokinetics and safety of first-line tuberculosis drugs rifampin, isoniazid, ethambutol, and pyrazinamide during pregnancy and postpartum: results from IMPAACT P1026sMarije Van Schalkwyk, Adrie Bekker, Eric Decloedt, et al.
AIDS (London, England)|November 30, 2020
Pharmacokinetics of tenofovir alafenamide with and without cobicistat in pregnant and postpartum women living with HIVKristina M Brooks, Jeremiah D Momper, Mauricio Pinilla, et al.
The Lancet. HIV|December 7, 2023
HIV-1 reservoir size after neonatal antiretroviral therapy and the potential to evaluate antiretroviral-therapy-free remission (IMPAACT P1115): a phase 1/2 proof-of-concept studyDeborah Persaud, Yvonne Bryson, Bryan S Nelson, et al.
The Pediatric Infectious Disease Journal|September 15, 2018
Congenital Cytomegalovirus and HIV Perinatal TransmissionKristina Adachi, Jiahong Xu, Bonnie Ank, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 15, 2015
Toward Earlier Inclusion of Pregnant and Postpartum Women in Tuberculosis Drug Trials: Consensus Statements From an International Expert PanelAmita Gupta, Jyoti S Mathad, Susan M Abdel-Rahman, et al.
The New England Journal of Medicine|June 22, 2012
Three postpartum antiretroviral regimens to prevent intrapartum HIV infectionKarin Nielsen-Saines, D Heather Watts, Valdilea G Veloso, et al.
Pageof 12